<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>168-NITRATE-DERIVATIVES-AND-RELATED.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="NITRATE DERIVATIVES AND RELATED" code="C01D-001" /></DRUG1>
<DRUG2>
<CLASS name="TYPE 5 PHOSPHODIESTERASE INHIBITORS" code="G04BE" /></DRUG2>
<DESCRIPTION>Risk of significant hypotension (synergic effect) capable of aggravating the state of myocardial ischemia and especially provoking an acute coronary accident</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>168-NITRATE-DERIVATIVES-AND-RELATED.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="NITRATE DERIVATIVES AND RELATED" code="C01D-001" /></DRUG1>
<DRUG2>
<CLASS name="MEDICATIONS THAT LOWER BLOOD PRESSURE " code="MLBP" /></DRUG2>
<DESCRIPTION>Increase of the risk of hypotension, especially orthostatic.</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>168-NITRATE-DERIVATIVES-AND-RELATED.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="NITRATE DERIVATIVES AND RELATED" code="C01D-001" /></DRUG1>
<DRUG2>
<DRUG name="RIOCIGUAT" rxcui="1439816">
<ATC code="C02KX05" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of significant hypotension (synergic effect).</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
